HIV infection is thought to lead to increased oxidative stress which may in
turn lead to faster progression of HIV disease. Therefore, antioxidants ma
y have a role in the treatment of HIV disease. We review the data on the re
lations of selected antioxidants to HIV disease progression. Results from o
bservational epidemiologic studies suggest that vitamin A deficiency may ac
celerate HIV disease progression. In observational studies conducted among
vitamin A replete populations, associations between intake or status of vit
amin A (both preformed vitamin A and R-carotene) and HIV disease progressio
n have been less consistent. Available data from intervention studies are n
ot entirely consistent with a beneficial effect of supplementation with pre
formed vitamin A or beta-carotene. The relations of vitamins C and E to HIV
disease progression have been examined in a small number of epidemiologic
studies; results from such studies are compatible with a protective effect
of high intakes or levels of these vitamins. In two prospective studies, lo
w selenium levels were found to be associated with an increased risk of pro
gression of HIV disease. Available epidemiologic data are consistent with a
protective effect of multivitamin (or multivitamin-mineral) supplements, p
reparations which typically include several of the above antioxidants. Fina
lly, limited epidemiologic data support a protective role of N-acetylcystei
ne (NAC) in HIV disease. Many studies conducted to date have been observati
onal prospective studies; the interpretation of such studies is problematic
, however, given the possibility of confounding by infection duration and o
ther factors. Thus, well designed randomized trials are essential to proper
ly investigate the role of antioxidants, particularly vitamin E, vitamin C,
selenium, and NAG, in HIV disease. Such trials are urgently needed since d
ietary administration of antioxidants to HIV infected persons would be an i
nexpensive intervention appropriate for the developing world. (C) 1999 Else
vier Science Inc.